STOCK TITAN

PEDEVCO: SGK trust buys 147,070 common shares

PEDEVCO Corp. (PED) reports that The SGK 2018 Revocable Trust purchased 147,070 common shares on October 8, 2026, at $13 per share.

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

PEDEVCO Corp. (PED) reports that The SGK 2018 Revocable Trust purchased 147,070 common shares on October 8, 2026, at $13 per share. Dr. Simon Kukes is the trust’s trustee; a footnote says the report is not an admission that he beneficially owns the trust shares except to the extent of his pecuniary interest. No Rule 10b5-1 plan is reported. A separate entry lists 150 shares held indirectly by his spouse.

Insights

Analyzing...

Insider KUKES SIMON G, SGK 2018 REVOCABLE TRUST
Role 10% Owner | Chief Executive Officer
Bought 147,070 shs ($1.91M)
Type Security Shares Price Value
Purchase Common Stock F1 147,070 $13.00 $1.91M
holding Common Stock F2 -- -- --
holding Common Stock F3 -- -- --
Holdings After Transaction: Common Stock — 4,543,640 shares (Direct); Common Stock — 150 shares (Indirect, By Spouse)
Footnotes (3)
  1. F1. Shares held by The SGK 2018 Revocable Trust, of which Dr. Simon Kukes is the trustee. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. F2. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  3. F3. Shares held directly by Dr. Simon Kukes.
Common shares purchased 147,070 shares By The SGK 2018 Revocable Trust on October 8, 2026
Purchase price $13 per share Trust purchase on October 8, 2026
Shares held indirectly by spouse 150 shares Separate holding entry dated October 8, 2026
pecuniary interest regulatory
"Except to the extent of his pecuniary interest therein"
beneficial owner regulatory
"beneficial owner of these securities"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
trustee regulatory
"Dr. Simon Kukes is the trustee"
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PED shares did the trust purchase?

The SGK 2018 Revocable Trust purchased 147,070 common shares of PEDEVCO Corp. on October 8, 2026, at $13 per share. No Rule 10b5-1 plan is reported for the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KUKES SIMON G

(Last)(First)(Middle)
575 N. DAIRY ASHFORD
ENERGY CENTER II, SUITE 210

(Street)
HOUSTON TEXAS 77079

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PEDEVCO CORP [ PED ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/08/2026P147,070A$134,137,543D(1)
Common Stock150I(2)By Spouse
Common Stock406,097D(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
KUKES SIMON G

(Last)(First)(Middle)
575 N. DAIRY ASHFORD
ENERGY CENTER II, SUITE 210

(Street)
HOUSTON TEXAS 77079

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
SGK 2018 REVOCABLE TRUST

(Last)(First)(Middle)
575 N. DAIRY ASHFORD
ENERGY CENTER II, SUITE 210

(Street)
HOUSTON TEXAS 77079

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
Explanation of Responses:
1. Shares held by The SGK 2018 Revocable Trust, of which Dr. Simon Kukes is the trustee. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3. Shares held directly by Dr. Simon Kukes.
Remarks:
See the Power of Attorney filed as Exhibit 24.1 to the Form 4 filed by the Reporting Persons on June 19, 2019 and the Power of Attorney filed as Exhibit 24.3 to the Form 4 filed by the Reporting Persons on October 5, 2022.
/s/ Clark R. Moore, attorney-in-fact for Simon Kukes10/12/2026
/s/ Clark R. Moore, attorney-in-fact for Simon Kukes, as Trustee of The SGK 2018 Revocable Trust10/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading